UNSPSC 51351619: Estradiol acetate

This classification denotes an estrogen C20H26O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5R97F5H93P, chemically known as estra-1,3,5(10)-triene-3,17-diol, (17.beta.)-, 3-acetate, but more generally known as estradiol acetate, which bears US NIH Compound Identifier 157050. European Medicines Agency schedules Estradiol acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB27089. Most nations, for tariff and trade purposes, schedule estradiol acetate under HS 29372300 and SITC 54153.

As of Q4 2014, ESTRADIOL ACETATE remains US FDA's Preferred Term for this commodity. Estradiol acetate bears US NLM identifiers UMLS ID C1330622 and NCI Concept Code C47990. SMILES: CC(=O)OC1CCC2C(C1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C.

UNSPSC 51351619 Estradiol acetate is a Commodity code identifying a specific pharmaceutical active ingredient used in hormone replacement therapy and other clinical applications. State and local governments procure this substance primarily through health department contracts, correctional facility pharmacy programs, and public health clinics serving medically underserved populations. The code describes a discrete chemical compound rather than a service category, so procurement typically occurs as part of larger pharmaceutical supply contracts or specialty medication acquisitions rather than as standalone line items.

The source provides no recent state and local contract opportunities explicitly tagged to this code. Without visibility into active solicitations, geographic distribution, or issuing-body patterns, no recommendation on pursuit can be made at this time.